Teva Chief Claims Credit For US Stability

Led The Industry On Portfolio Rationalization

 
• By Aidan Fry

By getting out of unprofitable product lines, Teva showed the way for industry to stabilize pricing and value in the US retail generics sector, the Israeli group’s president and CEO Kåre Schultz told investors at a J.P. Morgan conference.

Kare Schultz
Teva chief Kåre Schultz says his company led the way on restoring stability to the US retail generics sector • Source: Teva

More from Drug Pricing

More from Policy & Regulation